Citation: | ZHANG Gang, REN Qujun, CHENG Zemin. Correlations of microRNA-138 and microRNA-143 expression with prognosis in patients with non-muscle invasive bladder cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(8): 86-90. DOI: 10.7619/jcmp.20214765 |
[1] |
KAMAT A M, BAGCIOGLU M, HURI E. What is new in non-muscle-invasive bladder cancer in 2016[J]. Turkish J Urol, 2017, 43(1): 9-13. doi: 10.5152/tud.2017.60376
|
[2] |
王华, 李方印, 章伟. 非肌层浸润性膀胱癌治疗现状及进展[J]. 肿瘤学杂志, 2017, 23(7): 578-586. https://www.cnki.com.cn/Article/CJFDTOTAL-XHON201707004.htm
|
[3] |
MARCQ G, HÉNON F, OUZAID I, et al. Active surveillance for non-muscle invasive bladder cancer[J]. Transl Androl Urol, 2019, 8(1): 54-60. doi: 10.21037/tau.2018.10.20
|
[4] |
周致远, 唐旭东. 外泌体源性miRNA在肿瘤发生发展中作用的研究进展[J]. 生命科学, 2019, 31(6): 551-557. https://www.cnki.com.cn/Article/CJFDTOTAL-SMKX201906005.htm
|
[5] |
黄卓雅, 缪伟贤, 王晓冰, 等. miR-138靶向调控SIRT1表达及其对膀胱癌细胞增殖和凋亡的影响[J]. 临床肿瘤学杂志, 2017, 22(4): 298-302. doi: 10.3969/j.issn.1009-0460.2017.04.002
|
[6] |
刘孝德, 张鹏. miR-143/145启动子区rs4705341多态性与膀胱癌的关联[J]. 现代泌尿生殖肿瘤杂志, 2018, 10(2): 107-110. doi: 10.3870/j.issn.1674-4624.2018.02.012
|
[7] |
王金华, 吴小候. 非肌层浸润性膀胱癌预后相关分子标志物的研究进展[J]. 重庆医学, 2018, 47(17): 2344-2346. doi: 10.3969/j.issn.1671-8348.2018.17.024
|
[8] |
李欣, 罗小玲. miRNA调控肿瘤微环境的研究进展[J]. 现代免疫学, 2019, 39(3): 245-248. https://www.cnki.com.cn/Article/CJFDTOTAL-SHMY201903014.htm
|
[9] |
YANG R, LIU M H, LIANG H W, et al. miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells[J]. Mol Cancer, 2016, 15(1): 82. doi: 10.1186/s12943-016-0569-4
|
[10] |
WANG Y, WANG G, JI L, et al. Downregulation of miR-138-5p is associated with poor prognosis in human bladder cancer[J]. Int J Exp Pathol, 2017, 10(5): 5624-5629.
|
[11] |
LI M S, LIU Y L, LIU J, et al. Circ_0006332 promotes growth and progression of bladder cancer by modulating MYBL2 expression via miR-143[J]. Aging, 2019, 11(22): 10626-10643. doi: 10.18632/aging.102481
|
[12] |
程鸣佳, 储沨婷, 沈刚. miR-138与肿瘤的研究进展[J]. 肿瘤, 2017, 37(12): 1334-1338. doi: 10.3781/j.issn.1000-7431.2017.44.357
|
[13] |
王秋爽, 王琦, 孙华文, 等. microRNA-138通过靶向作用于CCND1抑制结肠癌细胞增殖[J]. 临床和实验医学杂志, 2020, 19(7): 733-737. doi: 10.3969/j.issn.1671-4695.2020.07.018
|
[14] |
SÅNCHEZ-GONZÅLEZ Å, BLANCA-PEDREGOSA A, CARRASCO-VALIENTE J, et al. Expression of the microRNAs miR-100, miR-138 y miR-let-7c in non-muscle invasive bladder cancer: clinicopathological significance and prognostic value[J]. Eur Urol Suppl, 2018, 17(14): e3002-e3003. doi: 10.1016/S1569-9056(18)33840-5
|
[15] |
TOKUMARU Y, TAKABE K, YOSHIDA K, et al. Effects of MIR143 on rat sarcoma signaling networks in solid tumors: a brief overview[J]. Cancer Sci, 2020, 111(4): 1076-1083. doi: 10.1111/cas.14357
|
[16] |
薛炜, 邱建新, 桑楠, 等. 影响非肌层浸润性膀胱癌患者经尿道膀胱肿瘤电切术后复发的相关因素分析[J]. 实用医院临床杂志, 2019, 16(5): 30-33. doi: 10.3969/j.issn.1672-6170.2019.05.009
|
[17] |
申龙, 连帆, 范文哲, 等. 非肌层浸润性膀胱癌TURBT术后髂内动脉灌注化学治疗疗效的影响因素分析[J]. 新医学, 2018, 49(2): 99-104. doi: 10.3969/j.issn.0253-9802.2018.02.006
|
[18] |
叶俊兵, 李王坚, 万俊彦, 等. 非肌层浸润性膀胱癌治疗的研究进展[J]. 国际泌尿系统杂志, 2020, 40(5): 938-941. doi: 10.3760/cma.j.cn431460-20190530-00051
|
[19] |
SEGOVIA C, MARTÍNEZ-FERNÅNDEZ M, DUEÑAS M, et al. Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer[J]. Oncotarget, 2017, 8(6): 10531-10542. doi: 10.18632/oncotarget.14453
|
[20] |
KAMAL M T, MAHER R S, MAHMOUD I T, et al. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis[J]. Cell Biochem Funct, 2016, 34(3): 142-148. doi: 10.1002/cbf.3171
|